SCHEMBL2824495

SCHEMBL2824495

O=C(C(=O)c1ccc(F)c(Br)c1)c1cccc(OC(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.48
KMT2A Q03164 3/20 0.48
NPSR1 Q6W5P4 3/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 2/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
SMN1; SMN2 Q16637 4/20 0.43
GAA P10253 1/20 0.43
ATM Q13315 1/20 0.43
NPC1 O15118 4/20 0.43
ALOX15 P16050 1/20 0.42
GFER P55789 1/20 0.42
ADAM17 P78536 1/20 0.42
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791543 0.88 ALOX15 (0.51) RAB9AKMT2AMEN1MAPTLMNA
SCHEMBL4785839 0.84 CES2 (0.68) RAB9AKMT2ANPSR1MEN1MAPT
SCHEMBL2821243 0.82 CES2 (0.50) RAB9AKMT2ANPSR1MEN1MAPT
SCHEMBL15955568 0.79 CES2 (0.55) RAB9AKMT2ANPSR1MEN1MAPT
SCHEMBL4784600 0.78 IDO1 (0.57) RAB9ACES2CES1
SCHEMBL4313438 0.78 CES2 (0.40) RAB9AKMT2AMEN1MAPTLMNA
SCHEMBL4309529 0.77 CES2 (0.39) RAB9AMAPTLMNACES2CES1
SCHEMBL2792829 0.77 ALOX15 (0.51) RAB9AKMT2ANPSR1MEN1MAPT
SCHEMBL29888754 0.76 ALOX15 (0.43) RAB9AKMT2ANPSR1MEN1MAPT
SCHEMBL15016881 0.76 ALOX15 (0.43) RAB9AKMT2ANPSR1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase WYETH LLC (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168194-A1 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone Compounds For The Inhibition Of Beta-secretase BACE1, BACE2, APP RAB9A 2147/4885KMT2A 2617/4885NPSR1 2624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.